Arsenic is associated with reduced effect of folic acid in myelomeningocele prevention: A case control study in Bangladesh

Environmental Health: A Global Access Science Source

Volumn 14, Issue 1, 2015, Pages

  Mazumdar, Maitreyi ^a,b   Ibne Hasan, Md Omar Sharif ^c   Hamid, Rezina ^d   Valeri, Linda ^b   Paul, Ligi ^e   Selhub, Jacob ^e   Rodrigues, Ema G ^a,b   Silva, Fareesa ^a   Mia, Selim ^c   Mostofa, Md Golam ^c   Quamruzzaman, Quazi ^c   Rahman, Mahmuder ^c   Christiani, David C ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Dhaka Community Hospital   (Bangladesh)

^d Bangladesh Medical College   (Bangladesh)

^e TUFTS UNIVERSITY   (United States)

Author keywords

Arsenic; Birth defect; Folate deficiency; Myelomeningocele; Neural tube defect

Indexed keywords

ARSENIC; DRINKING WATER; FOLIC ACID; WATER POLLUTANT;

ABNORMALITY; ARSENIC; CHILD CARE; COMMUNITY HEALTH WORKER; DRINKING WATER; EMBRYONIC DEVELOPMENT; GROUNDWATER POLLUTION; HEALTH SERVICES; HOSPITAL SECTOR; NEUROLOGY; POLLUTION EXPOSURE; PREGNANCY; RISK FACTOR; RURAL AREA; VITAMIN;

ADULT; ARSENIC POISONING; ARTICLE; BANGLADESH; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; NEWBORN; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; YOUNG ADULT; ANALYSIS; CHEMICALLY INDUCED; DIETARY SUPPLEMENT; ENVIRONMENTAL EXPOSURE; INFANT; METABOLISM; PREGNANCY; TOXICITY; WATER POLLUTANT;

BANGLADESH; DHAKA [BANGLADESH];

ANIMALIA;

ARSENIC; BANGLADESH; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOMYELOCELE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; WATER POLLUTANTS, CHEMICAL;

EID: 84927923067     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/s12940-015-0020-0     Document Type: Article

References (43)

1. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia: Saunders/Elsevier; 2008.
2. Williams J, Mai CT, Mulinare J, Isenburg J, Flood TJ, Ethen M, et al. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep. 2015;64(1):1-5.
3. Li Z, Ren A, Zhang L, Ye R, Li S, Zheng J, et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol. 2006;76(4):237-40.
4. Agopian AJ, Tinker SC, Lupo PJ, Canfield MA, Mitchell LE. National birth defects prevention S: proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol. 2013;97(1):42-6.
5. Hill DS, Wlodarczyk BJ, Finnell RH. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model. Birth Defects Res B Dev Reprod Toxicol. 2008;83(1):40-7.
6. Beaudoin AR. Teratogenicity of sodium arsenate in rats. Teratology. 1974;10(2):153-7.
7. Carpenter SJ. Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos. Anat Embryol. 1987;176(3):345-65.
8. Han ZJ, Song G, Cui Y, Xia HF, Ma X. Oxidative stress is implicated in arsenic-induced neural tube defects in chick embryos. Int J Dev Neurosci. 2011;29(7):673-80.
9. Hanlon DP, Ferm VH. Placental permeability of arsenate ion during early embryogenesis in the hamster. Experientia. 1977;33(9):1221-2.
10. Hill DS, Wlodarczyk BJ, Mitchell LE, Finnell RH. Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model. Toxicol Appl Pharmacol. 2009;239(1):29-36.
11. Wlodarczyk BJ, Zhu H, Finnell RH. Mthfr gene ablation enhances susceptibility to arsenic prenatal toxicity. Toxicol Appl Pharmacol. 2014;275(1):22-7.
12. Feng Y, Wang S, Chen R, Tong X, Wu Z, Mo X. Maternal folic Acid supplementation and the risk of congenital heart defects in offspring: a meta-analysis of epidemiological observational studies. Sci Rep. 2015;5:8506.
13. Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78(9):1093-103.
14. Chakraborti D, Rahman MM, Das B, Murrill M, Dey S, Chandra Mukherjee S, et al. Status of groundwater arsenic contamination in Bangladesh: a 14-year study report. Water Res. 2010;44(19):5789-802.
15. Dey AC, Shahidullah M, Mannan MA, Noor MK, Saha L, Rahman SA. Maternal and neonatal serum zinc level and its relationship with neural tube defects. J Health Popul Nutr. 2010;28(4):343-50.
16. Chen Y, Ahsan H, Parvez F, Howe GR. Validity of a food-frequency questionnaire for a large prospective cohort study in Bangladesh. Br J Nutr. 2004;92(5):851-9.
17. Horne DW, Patterson D. Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin Chem. 1988;34(11):2357-9.
18. Rothman KJ, Greenland S. Matching. In: Rothman KJ, Greenland S, editors. Modern Epidemiology. 2nd ed. New York: Lippincott, Williams & Wilkins; 1998. p. 147-61.
19. Rothman KJ, Greenland S. Introduction to Regression Modelling. In: Rothman KJ, Greenland S, editors. Modern Epidemiology. 2nd ed. New York: Lippincott, Williams & Wilkins; 1998. p. 401-34.
20. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278-95.
21. Baqui AH, El-Arifeen S, Darmstadt GL, Ahmed S, Williams EK, Seraji HR, et al. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Lancet. 2008;371(9628):1936-44.
22. Silva-Pinto V, Arriaza B, Standen V. [Spina bifida occulta associated with environmental arsenic exposure in a prehispanic sample from northern Chile]. Rev Med Chil. 2010;138(4):461-9.
23. Brender JD, Suarez L, Felkner M, Gilani Z, Stinchcomb D, Moody K, et al. Maternal exposure to arsenic, cadmium, lead, and mercury and neural tube defects in offspring. Environ Res. 2006;101(1):132-9.
24. Kwok RK, Kaufmann RB, Jakariya M. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. J Health Popul Nutr. 2006;24(2):190-205.
25. Wu J, Chen G, Liao Y, Song X, Pei L, Wang J, et al. Arsenic levels in the soil and risk of birth defects: a population-based case-control study using GIS technology. J Environ Health. 2011;74(4):20-5.
26. DeSesso JM. Teratogen update: inorganic arsenic. Teratology. 2001;64(3):170-3.
27. Dhar RK, Zheng Y, Stute M, van Geen A, Cheng Z, Shanewaz M, et al. Temporal variability of groundwater chemistry in shallow and deep aquifers of Araihazar, Bangladesh. J Contam Hydrol. 2008;99(1-4):97-111.
28. Concha G, Vogler G, Nermell B, Vahter M. Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water. Int Arch Occup Environ Health. 1998;71(1):42-6.
29. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, et al. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect. 2007;115(10):1503-9.
30. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, Factor-Litvak P, et al. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr. 2007;86(4):1202-9.
31. Shaw GM, Todoroff K, Finnell RH, Lammer EJ. Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology. 2000;61(5):376-81.
32. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003;111(5 Pt 2):1152-8.
33. Soler NG, Walsh CH, Malins JM. Congenital malformations in infants of diabetic mothers. Q J Med. 1976;45(178):303-13.
34. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007;161(8):745-50.
35. Hendricks KA, Nuno OM, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 2001;12(6):630-5.
36. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996;275(14):1089-92.
37. Pan WC, Seow WJ, Kile ML, Hoffman EB, Quamruzzaman Q, Rahman M, et al. Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh. Am J Epidemiol. 2013;178(10):1563-70.
38. Kuo CC, Moon K, Thayer KA, Navas-Acien A. Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep. 2013;13(6):831-49.
39. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. Evaluation of the association between arsenic and diabetes: a national toxicology program workshop review. Environ Health Perspect. 2012;120(12):1658-70.
40. Ettinger AS, Zota AR, Amarasiriwardena CJ, Hopkins MR, Schwartz J, Hu H, et al. Maternal arsenic exposure and impaired glucose tolerance during pregnancy. Environ Health Perspect. 2009;117(7):1059-64.
41. Zangen SW, Yaffe P, Shechtman S, Zangen DH, Ornoy A. The role of reactive oxygen species in diabetes-induced anomalies in embryos of Cohen diabetic rats. Int J Exp Diabetes Res. 2002;3(4):247-55.
42. Yang P, Li X, Xu C, Eckert RL, Reece EA, Zielke HR, et al. Maternal hyperglycemia activates an ASK1-FoxO3a-caspase 8 pathway that leads to embryonic neural tube defects. Science signaling. 2013;6(290):ra74.
43. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2007;79(3):187-210.